Inodiftagene vixteplasmid
维因塔基
Report date: 2024/09/26 15:33:58
Base Information
Drug NameInodiftagene vixteplasmid
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiocancell Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAnchiano Therapeutics Israel LtdThe Hebrew University Of Jerusalem
Active IndicationsN/A
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A